MVP and asthma: In terms of interactions with YPEL4, specific inhibitors of MVP may allow the MAPK pathway to work alongside the PI3K pathway simultaneously, suggesting that specific inhibitors of MVP may serve as therapeutic targets for asthma by promoting the activity of YPEL4 [69].